PRESTINENZI, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 446
EU - Europa 316
AS - Asia 179
AF - Africa 28
Totale 969
Nazione #
US - Stati Uniti d'America 446
GB - Regno Unito 81
CN - Cina 74
SE - Svezia 64
SG - Singapore 52
DE - Germania 46
IT - Italia 42
VN - Vietnam 21
IE - Irlanda 20
IN - India 18
RU - Federazione Russa 15
TG - Togo 11
UA - Ucraina 11
FR - Francia 10
BG - Bulgaria 9
ZA - Sudafrica 9
JO - Giordania 8
BE - Belgio 6
NG - Nigeria 5
EE - Estonia 4
CH - Svizzera 3
CI - Costa d'Avorio 3
FI - Finlandia 3
IR - Iran 3
AE - Emirati Arabi Uniti 1
CZ - Repubblica Ceca 1
JP - Giappone 1
NL - Olanda 1
TW - Taiwan 1
Totale 969
Città #
Southend 72
Chandler 52
Singapore 48
Fairfield 39
Ashburn 34
Ann Arbor 29
Wilmington 26
Princeton 24
Dong Ket 21
Seattle 21
Dublin 20
Houston 19
Cambridge 18
Santa Clara 18
Woodbridge 16
Boardman 14
New York 14
Nanjing 13
Lomé 11
Bremen 9
Padova 9
Sofia 9
Turin 9
Westminster 9
Amman 8
Jinan 7
Berlin 6
Brussels 6
Medford 6
Shenyang 6
Abeokuta 5
Bologna 5
Jacksonville 5
Mülheim 5
Hebei 4
Jiaxing 4
Kuban 4
Los Angeles 4
Redwood City 4
Abidjan 3
Changsha 3
Helsinki 3
Saint Petersburg 3
San Diego 3
San Venanzo 3
Taiyuan 3
Tianjin 3
Zhengzhou 3
Bari 2
Beijing 2
Bern 2
Dearborn 2
Guangzhou 2
Olalla 2
Redmond 2
Taizhou 2
Zanjan 2
Adliswil 1
Changchun 1
Costa Mesa 1
Den Haag 1
Dongguan 1
Dubai 1
Florence 1
Frankfurt am Main 1
Haikou 1
Hangzhou 1
Hefei 1
Huaibei 1
Kunming 1
Moscow 1
Munich 1
Nanchang 1
Orange 1
Plauen 1
Qingdao 1
Ravenna 1
Shanghai 1
Wuhan 1
Xiamen 1
Yangzhou 1
Yuncheng 1
Totale 703
Nome #
Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: Long-term follow-up of the SHIRAKISS randomized, prospective study. 124
Clinical and Prognostic Correlates of pAMR Grading in Patients with Suspect Antibody Mediated Rejection 121
Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. 121
Differential Effect of Everolimus and Metabolic Risk Factors on Early vs. Late Progression of Allograft Vasculopathy: Dissecting Two Faces of the Same Disease 113
Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation 113
EVEROLIMUS REDUCES CAV PROGRESSION AS COMPARED WITH AZATHIOPRINE AND MYCOPHENOLATE: A LONGITUDINAL IVUS- BASED STUDY 107
Differential Effects of Everolimus on Early vs. Late Allograft Vasculopathy Progression in Heart Transplant Recipients: a Longitudinal IVUS-Based Study 103
PREDICTING CARDIOVASCULAR OUTCOMES LONG-TERM AFTER HEART TRANSPLANT BY LATE CHANGES IN MAXIMAL INTIMAL THICKNESS: BEYOND THE HYSTORICAL 1-YEAR LIMIT 101
Late Changes in Maximal Intimal Thickness after Heart Transplant: Prognostic Implications and Risk Factors 96
Totale 999
Categoria #
all - tutte 2.477
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.477


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020110 0 0 0 0 0 0 23 17 29 11 7 23
2020/2021114 29 3 11 9 1 4 5 2 13 5 2 30
2021/2022169 11 5 4 19 18 6 2 10 7 25 31 31
2022/2023234 28 42 16 28 17 17 5 7 40 6 20 8
2023/202463 4 10 1 9 1 30 0 1 0 4 1 2
2024/2025125 12 39 30 13 24 7 0 0 0 0 0 0
Totale 999